Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Przybyl, Joanna ^a,b,c   Jurkowska, Monika ^a   Rutkowski, Piotr ^a   Debiec Rychter, Maria ^c   Siedlecki, Janusz A ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CANCER TESTIS ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EARLY GROWTH RESPONSE FACTOR 1; HISTONE DEACETYLASE; HYBRID PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN P53; PROTEIN SS18 SSX1; PROTEIN SS18 SSX2; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; XRCC4 PROTEIN;

CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; DNA BINDING; DNA DAMAGE; GENE EXPRESSION; GENE FUNCTION; HUMAN; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYNOVIAL SARCOMA; TRANSCRIPTION INITIATION;

EID: 84859718546     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/249219     Document Type: Review

References (153)

1. Sandberg A. A., Bridge J. A., Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms Cancer Genetics and Cytogenetics 2003 143 1 1 31 (Pubitemid 36549004)
2. Fukukawa C., Nakamura Y., Katagiri T., Molecular target therapy for synovial sarcoma Future Oncology 2005 1 6 805 812
3. Ishibe T., Nakayama T., Aoyama T., Nakamura T., Toguchida J., Neuronal differentiation of synovial sarcoma and its therapeutic application Clinical Orthopaedics and Related Research 2008 466 9 2147 2155
4. Haldar M., Hancock J. D., Coffin C. M., Lessnick S. L., Capecchi M. R., A conditional mouse model of synovial sarcoma: insights into a myogenic origin Cancer Cell 2007 11 4 375 388 (Pubitemid 46518310)
5. Naka N., Takenaka S., Araki N., Miwa T., Hashimoto N., Yoshioka K., Joyama S., Hamada K. I., Tsukamoto Y., Tomita Y., Ueda T., Yoshikawa H., Itoh K., Synovial sarcoma is a stem cell malignancy Stem Cells 2010 28 7 1119 1131
6. Garcia C. B., Shaffer C. M., Alfaro M. P., Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene. In press
7. Duband S., Morrison A. L., Pasquier D., Coindre J. M., Pasquier B., Péoc'h M., First case report of a fetal synovial sarcoma confirmed by molecular detection of SYT-SSX fusion gene transcripts American Journal of Perinatology 2008 25 8 517 520
8. Ladanyi M., Fusions of the SYT and SSX genes in synovial sarcoma Oncogene 2001 20 40 5755 5762 (Pubitemid 32928113)
9. Panagopoulos I., Mertens F., Isaksson M., Limon J., Gustafson P., Skytting B., kerman M., Sciot R., Cin P. D., Samson I., Iliszko M., Ryoe J., Dbiec-Rychter M., Szadowska A., Brosj O., Larsson O., Rydholm A., Mandahl N., Clinical impact of molecular and cytogenetic findings in synovial sarcoma Genes Chromosomes and Cancer 2001 31 4 362 372 (Pubitemid 32622713)
10. Ladanyi M., Antonescu C. R., Leung D. H., Woodruff J. M., Kawai A., Healey J. H., Brennan M. F., Bridge J. A., Neff J. R., Barr F. G., Goldsmith J. D., Brooks J. S. J., Goldblum J. R., Ali S. Z., Shipley J., Cooper C. S., Fisher C., Skytting B., Larsson O., Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients Cancer Research 2002 62 1 135 140 (Pubitemid 34073997)
11. Fernebro J., Francis P., Edén P., Borg.., Panagopoulos I., Mertens F., Vallon-Christersson J., kerman M., Rydholm A., Bauer H. C. F., Mandahl N., Nilbert M., Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma International Journal of Cancer 2006 118 5 1165 1172 (Pubitemid 43185603)
12. Nakayama R., Mitani S., Nakagawa T., Hasegawa T., Kawai A., Morioka H., Yabe H., Toyama Y., Ogose A., Toguchida J., Nakayama T., Yoshida T., Ichikawa H., Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type American Journal of Surgical Pathology 2010 34 11 1599 1607
13. Miettinen M., Keratin subsets in spindle cell sarcomas. Keratins ae widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins American Journal of Pathology 1991 138 2 505 513
14. Pelmus M., Guillou L., Hostein I., Sierankowski G., Lussan C., Coindre J. M., Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases American Journal of Surgical Pathology 2002 26 11 1434 1440 (Pubitemid 35239419)
15. Olsen S. H., Thomas D. G., Lucas D. R., Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma Modern Pathology 2006 19 5 659 668
16. Terry J., Saito T., Subramanian S., Ruttan C., Antonescu C. R., Goldblum J. R., Downs-Kelly E., Corless C. L., Rubin B. P., Van De Rijn M., Ladanyi M., Nielsen T. O., TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies American Journal of Surgical Pathology 2007 31 2 240 246 (Pubitemid 46175025)
17. Jagdis A., Rubin B. P., Tubbs R. R., Pacheco M., Nielsen T. O., Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma American Journal of Surgical Pathology 2009 33 12 1743 1751
18. Knsel T., Heretsch S., Altendorf-Hofmann A., Richter P., Katenkamp K., Katenkamp D., Berndt A., Petersen I., TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases European Journal of Cancer 2010 46 6 1170 1176
19. Limon J., Dal Cin P., Sandberg A. A., Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t[X;18][q13;p11] Cancer Genetics and Cytogenetics 1986 23 1 87 91 (Pubitemid 16051843)
20. Turc-Carel C., Dal Cin P., Limon J., Li F., Sandberg A. A., Translocation X;18 in synovial sarcoma Cancer Genetics and Cytogenetics 1986 23 1 93
21. Mitelman F., Johansson B., Mertens F., Mitelman database of chromosome aberrations in cancer 2011. http://cgap.nci.nih.gov/Chromosomes/Mitelman
22. Gre A. O., Wei I. J., Old L. J., Chen Y. T., The SSX gene family: characterization of 9 complete genes International Journal of Cancer 2002 101 5 448 453
23. Brett D., Whitehouse S., Antonson P., Shipley J., Cooper C., Goodwin G., The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies Human Molecular Genetics 1997 6 9 1559 1564 (Pubitemid 27397034)
24. dos Santos N. R., de Bruijn D. R. H., Balemans M., Janssen B., Grtner F., Lopes J. M., De Leeuw B., Van Kessel A. G., Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins Human Molecular Genetics 1997 6 9 1549 1558 (Pubitemid 27397033)
25. Perani M., Antonson P., Hamoudi R., Ingram C. J. E., Cooper C. S., Garrett M. D., Goodwin G. M., The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins Journal of Biological Chemistry 2005 280 52 42863 42876 (Pubitemid 43049249)
26. Iwasaki T., Koibuchi N., Chin W. W., Synovial sarcoma translocation (SYT) encodes a nuclear receptor coactivator Endocrinology 2005 146 9 3892 3899 (Pubitemid 41175759)
27. Eid J. E., Kung A. L., Scully R., Livingston D. M., p300 Interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion Cell 2000 102 6 839 848
28. Kimura T., Sakai M., Tabu K., Wang L., Tsunematsu R., Tsuda M., Sawa H., Nagashima K., Nishihara H., Hatakeyama S., Nakayama K., Ladanyi M., Tanaka S., Nakayama K. I., Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration Laboratory Investigation 2009 89 6 645 656
29. de Bruijn D. R. H., Dos Santos N. R., Thijssen J., Balemans M., Debernardi S., Linder B., Young B. D., Geurts Van Kessel A., The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10 Oncogene 2001 20 25 3281 3289 (Pubitemid 32553680)
30. Thaete C., Brett D., Monaghan P., Whitehouse S., Rennie G., Rayner E., Cooper C. S., Goodwin G., Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus Human Molecular Genetics 1999 8 4 585 591 (Pubitemid 29139971)
31. Perani M., Ingram C. J. E., Cooper C. S., Garrett M. D., Goodwin G. H., Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers Oncogene 2003 22 50 8156 8167 (Pubitemid 37487306)
32. Bandyopadhyay S., Chiang C. Y., Srivastava J., Gersten M., White S., Bell R., Kurschner C., Martin C. H., Smoot M., Sahasrabudhe S., Barber D. L., Chanda S. K., Ideker T., A human MAP kinase interactome Nature Methods 2010 7 10 801 805
33. Suzuki H., Fukunishi Y., Kagawa I., Saito R., Oda H., Endo T., Kondo S., Bono H., Okazaki Y., Hayashizaki Y., Protein-protein interaction panel using mouse full-length cDNAs Genome Research 2001 11 10 1758 1765 (Pubitemid 33040503)
34. Ito T., Ouchida M., Ito S., Jitsumori Y., Morimoto Y., Ozaki T., Kawai A., Inoue H., Shimizu K., SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex Laboratory Investigation 2004 84 11 1484 1490 (Pubitemid 39482165)
35. Kato H., Tjernberg A., Zhang W., Krutchinsky A. N., An W., Takeuchi T., Ohtsuki Y., Sugano S., De Bruijn D. R., Chait B. T., Roeder R. G., SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones Journal of Biological Chemistry 2002 277 7 5498 5505 (Pubitemid 34968600)
36. de Bruijn D. R. H., Peters W. J. M., Chuva de Sousa Lopes S. M., van Dijk A. H. A., Willemse M. P., Pfundt R., de Boer P., Geurts van Kessel A., Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression Human Molecular Genetics 2006 15 19 2936 2944 (Pubitemid 44446812)
37. Chittezhath M., Frump A. L., Jourquin J., Lobdell N., Eid J. E., The proto-oncoprotein SYT (SS18) controls ATP release and regulates cyst formation by polarized MDCK cells Experimental Cell Research 2008 314 19 3551 3562
38. Gre A. O., Treci O., Sahin U., Tsang S., Scanlan M. J., Jger E., Knuth A., Pfreundschuh M., Old L. J., Chen Y. T., SSX: a multigene family with several members transcribed in normal testis and human cancer International Journal of Cancer 1997 72 6 965 971 (Pubitemid 27433559)
39. Treci O., Chen Y. T., Sahin U., Gre A. O., Zwick C., Villena C., Tsang S., Seitz G., Old L. J., Pfreundschuh M., Expression of SSX genes in human tumors International Journal of Cancer 1998 77 1 19 23 (Pubitemid 28308546)
40. dos Santos N. R., Torensma R., De Vries T. J., Schreurs M. W. J., De Bruijn D. R. H., Kater-Baats E., Ruiter D. J., Adema G. J., Van Muijen G. N. P., Van Kessel A. G., Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines Cancer Research 2000 60 6 1654 1662 (Pubitemid 30183438)
41. Taylor B. J., Reiman T., Pittman J. A., Keats J. J., De Bruijn D. R. H., Mant M. J., Belch A. R., Pilarski L. M., SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs Journal of Immunotherapy 2005 28 6 564 575 (Pubitemid 41533090)
42. Andrade V. C., Vettore A. L., Felix R. S., Almeida M. S., Carvalho F., Oliveira J. S., Chauffaille M. L., Andriolo A., Caballero O. L., Zago M. A., Colleoni G. W., Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients Cancer Immunity 2008 8 2
43. Chi S. N., Cheung N. K. V., Cheung I. Y., Expression of SSX-2 and SSX-4 genes in neuroblastoma International Journal of Biological Markers 2002 17 4 219 223 (Pubitemid 36104335)
44. Lee M. H., Son E. I., Kim E., Kim I. S., Yim M. B., Kim S. P., Expression of cancer-testis genes in brain tumors Journal of Korean Neurosurgical Society 2008 43 4 190 193
45. Hasegawa K., Koizumi F., Noguchi Y., Hongo A., Mizutani Y., Kodama J., Hiramatsu Y., Nakayama E., SSX expression in gynecological cancers and antibody response in patients Cancer Immunity 2004 4 16
46. Utsunomiya T., Inoue H., Tanaka F., Yamaguchi H., Ohta M., Okamoto M., Mimori K., Mori M., Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma Annals of Surgical Oncology 2004 11 10 934 940 (Pubitemid 40486680)
47. Peng J. R., Chen H. S., Mou D. C., Cao J., Cong X., Qin L. L., Wei L., Leng X. S., Wang Y., Chen W. F., Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters Cancer Letters 2005 219 2 223 232 (Pubitemid 40269487)
48. Wu L. Q., Lu Y., Wang X. F., Lv Z. H., Zhang B., Yang J. Y., Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma Life Sciences 2006 79 8 744 748 (Pubitemid 43975124)
49. Valmori D., Qian F., Ayyoub M., Renner C., Merlo A., Gjnatic S., Stockert E., Driscoll D., Lele S., Old L. J., Odunsi K., Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells Clinical Cancer Research 2006 12 2 398 404 (Pubitemid 43166127)
50. Dubovsky J. A., McNeel D. G., Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor Prostate 2007 67 16 1781 1790 (Pubitemid 350228730)
51. Zhao L., Mou D. C., Peng J. R., Huang L., Wu Z. A., Leng X. S., Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients World Journal of Gastroenterology 2010 16 32 4072 4078
52. Treci O., Sahin U., Schobert I., Koslowski M., Schmitt H., Schild H. J., Stenner F., Seitz G., Rammensee H. G., Pfreundschuh M., The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40 Cancer Research 1996 56 20 4766 4772 (Pubitemid 26338082)
53. van Kessel A. G., dos Santos N. R., Simons A., De Bruijn D., Forus A., Fodstad O., Myklebost O., Balemans M., Baats E., Olde Weghuis D., Suijkerbuijk R. F., Van den Berg E., Molenaar W. M., De Leeuw B., Molecular cytogenetics of bone and soft tissue tumors Cancer Genetics and Cytogenetics 1997 95 1 67 73 (Pubitemid 27188449)
54. Naka N., Araki N., Nakanishi H., Itoh K., Mano M., Ishiguro S., De Bruijn D. R. H., Myoui A., Ueda T., Yoshikawa H., Expression of SSX genes in human osteosarcomas [2] International Journal of Cancer 2002 98 4 640 642 (Pubitemid 34208570)
55. Ayyoub M., Brehm M., Metthez G., Talbot S., Dutoit V., Taub R. N., Keohan M. L., Gure A. O., Chen Y. T., Williamson B., Jungbluth A. A., Old L. J., Hesdorffer C. S., Valmori D., SSX antigens as tumor vaccine targets in human sarcoma Cancer Immunity 2003 3 13
56. Segal N. H., Blachere N. E., Guevara-Patio J. A., Gallardo H. F., Shiu H. Y., Viale A., Antonescu C. R., Wolchok J. D., Houghton A. N., Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics. Cancer Immunity 2005 5 2
57. Naka N., Joyama S., Tsukamoto Y., Yoshioka K., Hashimoto N., Ujiiye T., Hayashi T., Kawase M., Mano M., Ishiguro S., Myoui A., Ueda T., Yoshikawa H., Araki N., Itoh K., Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification Journal of Molecular Diagnostics 2005 7 2 187 197 (Pubitemid 40668301)
58. Chen C. H., Chen G. J., Lee H. S., Huang G. T., Yang P. M., Tsai L. J., Chen D. S., Sheu J. C., Expressions of cancer-testis antigens in human hepatocellular carcinomas Cancer Letters 2001 164 2 189 195
59. Lim F. L., Soulez M., Koczan D., Thiesen H. J., Knight J. C., A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas Oncogene 1998 17 15 2013 2018 (Pubitemid 28488471)
60. Dimitriadis E., Rontogianni D., Kyriazoglou A., Takou A., Frangia K., Pandis N., Trangas T., Novel SYT-SSX fusion transcript variants in synovial sarcoma Cancer Genetics and Cytogenetics 2009 195 1 54 58
61. Soulez M., Saurin A. J., Freemont P. S., Knight J. C., SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex Oncogene 1999 18 17 2739 2746 (Pubitemid 29237662)
62. Cronwright G., Le Blanc K., Gtherstrm C., Darcy P., Ehnman M., Brodin B., Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression Cancer Research 2005 65 6 2207 2215 (Pubitemid 40490129)
63. de Bruijn D. R. H., dos Santos N. R., Kater-Baats E., Thijssen J., Van Den Berk L., Stap J., Balemans M., Schepens M., Merkx G., Van Kessel A. G., The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP Genes Chromosomes and Cancer 2002 34 3 285 298 (Pubitemid 34553307)
64. Crew A. J., Clark J., Fisher C., Gill S., Grimer R., Chand A., Shipley J., Gusterson B. A., Cooper C. S., Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma EMBO Journal 1995 14 10 2333 2340
65. Kawai A., Woodruff J., Healey J. H., Brennan M. F., Antonescu C. R., Ladanyi M., SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma New England Journal of Medicine 1998 338 3 153 160 (Pubitemid 28041862)
66. Guillou L., Benhattar J., Bonichon F., Gallagher G., Terrier P., Stauffer E., De Saint Aubain Somerhausen N., Michels J. J., Jundt G., Vince D. R., Taylor S., Genevay M., Collin F., Trassard M., Coindre J. M., Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis Journal of Clinical Oncology 2004 22 20 4040 4050 (Pubitemid 41185173)
67. Skytting B., Nilsson G., Brodin B., Xie Y., Lundeberg J., Uhlen M., Larsson O., A novel fusion gene, SYT-SSX4, in synovial sarcoma [3] Journal of the National Cancer Institute 1999 91 11 974 975 (Pubitemid 29275883)
68. Brodin B., Haslam K., Yang K., Bartolazzi A., Xie Y., Starborg M., Lundeberg J., Larsson O., Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression Gene 2001 268 1-2 173 182 (Pubitemid 32463801)
69. Brodin B., Trnkvist M., Haslam K., Xie Y. Yunta., Bartolazzi A., Larsson O., Re: A novel fusion gene, SYT-SSX4, in synovial sarcoma Journal of the National Cancer Institute 2001 93 17 1347 1349 (Pubitemid 32910577)
70. Amary M. F. C., Diss T. C., Flanagan A. M., Molecular characterization of a novel variant of a SYT-SSX1 fusion transcript in synovial sarcoma [6] Histopathology 2007 51 4 559 561 (Pubitemid 47437837)
71. Nilsson G., Skytting B., Xie Y., Brodin B., Perfekt R., Mandahl N., Lundeberg J., Uhlén M., Larsson O., The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome Cancer Research 1999 59 13 3180 3184 (Pubitemid 29316020)
72. Antonescu C. R., Kawai A., Leung D. H., Lonardo F., Woodruff J. M., Healey J. H., Ladanyi M., Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma Diagnostic Molecular Pathology 2000 9 1 1 8 (Pubitemid 30131955)
73. Saito T., Nagai M., Ladanyi M., SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma Cancer Research 2006 66 14 6919 6927 (Pubitemid 44197666)
74. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia de Herreros A., The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nature Cell Biology 2000 2 2 84 89
75. Cano A., Pérez-Moreno M. A., Rodrigo I., Locascio A., Blanco M. J., del Barrio M. G., Portillo F., Nieto M. A., The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nature Cell Biology 2000 2 2 76 83
76. Ishida M., Miyamoto M., Naitoh S., Tatsuda D., Hasegawa T., Nemoto T., Yokozeki H., Nishioka K., Matsukage A., Ohki M., Ohta T., The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma Molecular and Cellular Biology 2007 27 4 1348 1355 (Pubitemid 46239817)
77. Inagaki H., Nagasaka T., Otsuka T., Sugiura E., Nakashima N., Eimoto T., Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma Modern Pathology 2000 13 5 482 488 (Pubitemid 30332098)
78. Sun Y., Sun B., Wang J., Cai W., Zhao X., Zhang S., Hao X., Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma Cancer Science 2009 100 6 1018 1025
79. Wei X., Sun Y., Zhao X., Cai W., Xia W., Lou D., Ban X., Sun B., The influence of SYT-SSX fusion gene, E-cadherin and -catenin on the metastasis of synovial sarcoma Chinese Journal of Clinical Oncology 2010 37 4 205 208
80. Ladanyi M., Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting? Journal of Clinical Oncology 2005 23 15 3638 3639
81. Takenaka S., Ueda T., Naka N., Araki N., Hashimoto N., Myoui A., Ozaki T., Nakayama T., Toguchida J., Tanaka K., Iwamoto Y., Matsumine A., Uchida A., Ieguchi M., Kaya M., Wada T., Baba I., Kudawara I., Aoki Y., Yoshikawa H., Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan Oncology Reports 2008 19 2 467 476 (Pubitemid 351176109)
82. Xie Y., Skytting B., Nilsson G., Grimer R. J., Mangham C. D., Fisher C., Shipley J., Bjerkehagen B., Myklebost O., Larsson O., The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery Oncogene 2002 21 37 5791 5796 (Pubitemid 35333013)
83. Peng C., Guo W., Yang Y., Zhao H., Downregulation of ss18-ssx1 expression by small interfering rna inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro European Journal of Cancer Prevention 2008 17 5 392 398
84. Xie Y., Skytting B., Nilsson G., Gasbarri A., Haslam K., Bartolazzi A., Brodin B., Mandahl N., Larsson O., SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation Cancer Research 2002 62 13 3861 3867 (Pubitemid 34728873)
85. Trnkvist M., Natalishvili N., Xie Y., Girnita A., D'Arcy P., Brodin B., Axelson M., Girnita L., Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth Biochemical and Biophysical Research Communications 2008 368 3 793 800
86. Pretto D., Barco R., Rivera J., Neel N., Gustavson M. D., Eid J. E., The synovial sarcoma translocation protein SYT-SSX2 recruits -catenin to the nucleus and associates with it in an active complex Oncogene 2006 25 26 3661 3669 (Pubitemid 43980487)
87. Hecht A., Kemler R., Curbing the nuclear activities of -catenin: control over Wnt target gene expression EMBO Reports 2000 1 1 24 28
88. Horvai A. E., Kramer M. J., O'Donnell R., -catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study Archives of Pathology and Laboratory Medicine 2006 130 6 792 798 (Pubitemid 43886997)
89. Bozzi F., Ferrari A., Negri T., Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation Translational Oncology 2008 1 2 95 101
90. Xie Y., Trnkvist M., Aalto Y., Nilsson G., Girnita L., Nagy B., Knuutila S., Larsson O., Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene Oncogene 2003 22 48 7628 7631 (Pubitemid 37464096)
91. D'Arcy P., Maruwge W., Ryan B. A., Brodin B., The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability Molecular Cancer Research 2008 6 1 127 138 (Pubitemid 351378173)
92. D'Arcy P., Ryan B. A., Brodin B., Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction Cancer Letters 2009 275 2 285 292
93. Tsuda M., Watanabe T., Seki T., Kimura T., Sawa H., Minami A., Akagi T., Isobe K. I., Nagashima K., Tanaka S., Induction of p21WAF1/CIP1 by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1 Oncogene 2005 24 54 7984 7990 (Pubitemid 41746742)
94. Lubieniecka J. M., de Bruijn D. R. H., Su L., Van Dijk A. H. A., Subramanian S., Van De Rijn M., Poulin N., Van Kessel A. G., Nielsen T. O., Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma Cancer Research 2008 68 11 4303 4310
95. de Bruijn D. R. H., Allander S. V., Van Dijk A. H. A., Willemse M. P., Thijssen J., Van Groningen J. J. M., Meltzer P. S., Van Kessel A. G., The synovial sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation Cancer Research 2006 66 19 9474 9482 (Pubitemid 44623645)
96. Su L., Cheng H., Sampaio A. V., Nielsen T. O., Underhill T. M., EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor Oncogene 2010 29 30 4352 4361
97. Sarver A. L., Li H., Subramanian S., MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration Cancer Research 2010 70 23 9570 9580
98. Cironi L., Provero P., Riggi N., Janiszewska M., Suva D., Suva M. L., Kindler V., Stamenkovic I., Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1 PLoS ONE 2009 4 11
99. Sun Y., Gao D., Liu Y., Huang J., Lessnick S., Tanaka S., IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1 Oncogene 2006 25 7 1042 1052 (Pubitemid 43277012)
100. Friedrichs N., Kchler J., Endl E., Koch A., Czerwitzki J., Wurst P., Metzger D., Schulte J. H., Holst M. I., Heukamp L. C., Larsson O., Tanaka S., Kawai A., Wardelmann E., Buettner R., Pietsch T., Hartmann W., Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma Journal of Pathology 2008 216 4 428 439
101. Xie Y., Skytting B., Nilsson G., Brodin B., Larsson O., Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype Cancer Research 1999 59 15 3588 3591 (Pubitemid 29381857)
102. Baserga R., The contradictions of the insulin-like growth factor 1 receptor Oncogene 2000 19 49 5574 5581
103. Allander S. V., Illei P. B., Chen Y., Antonescu C. R., Bittner M., Ladanyi M., Meltzer P. S., Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation American Journal of Pathology 2002 161 5 1587 1595 (Pubitemid 35265519)
104. Lee Y. F., John M., Edwards S., Clark J., Flohr P., Maillard K., Edema M., Baker L., Mangham D. C., Grimer R., Wooster R., Thomas J. M., Fisher C., Judson I., Cooper C. S., Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling British Journal of Cancer 2003 88 4 510 515 (Pubitemid 36363359)
105. Baird K., Davis S., Antonescu C. R., Harper U. L., Walker R. L., Chen Y., Glatfelter A. A., Duray P. H., Meltzer P. S., Gene expression profiling of human sarcomas: insights into sarcoma biology Cancer Research 2005 65 20 9226 9235 (Pubitemid 41507988)
106. Steigen S. E., Schaeffer D. F., West R. B., Nielsen T. O., Expression of insulin-like growth factor 2 in mesenchymal neoplasms Modern Pathology 2009 22 7 914 921
107. Cai W., Sun Y., Wang W., Han C., Ouchida M., Xia W., Zhao X., Sun B., The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in Synovial sarcoma Pathology and Oncology Research 2011 17 2 357 367
108. Arisan S., Buyuktuncer E. D., Palavan-Unsal N., akurlu T., akir O. O., Ergenekon E., Increased expression of EZH2, a polycomb group protein, in bladder carcinoma Urologia Internationalis 2005 75 3 252 257 (Pubitemid 41433876)
109. Berezovska O. P., Glinskii A. B., Yang Z., Li X. M., Hoffman R. M., Glinsky G. V., Essential role for activation of the polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer Cell Cycle 2006 5 16 1886 1901 (Pubitemid 44435335)
110. Mohty M., Yong A. S. M., Szydlo R. M., Apperley J. F., Melo J. V., The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia Blood 2007 110 1 380 383 (Pubitemid 47026858)
111. Snchez-Beato M., Snchez E., Gonzlez-Carrer J., Morente M., Dez A., Snchez-Verde L., Martn M. C., Cigudosa J. C., Vidal M., Piris M. A., Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays Modern Pathology 2006 19 5 684 694
112. Guo W. J., Zeng M. S., Yadav A., Song L. B., Guo B. H., Band V., Dimri G. P., Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells Cancer Research 2007 67 11 5083 5089 (Pubitemid 46997242)
113. dos Santos N. R., de Bruijn D. R. H., Kater-Baats E., Otte A. P., Van Kessel A. G., Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization Experimental Cell Research 2000 256 1 192 202 (Pubitemid 30211181)
114. Barco R., Garcia C. B., Eid J. E., The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1 PLoS ONE 2009 4 4
115. Ito T., Ouchida M., Morimoto Y., Yoshida A., Jitsumori Y., Ozaki T., Sonobe H., Inoue H., Shimizu K., Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo Cancer Letters 2005 224 2 311 319 (Pubitemid 40725851)
116. Nagai M., Tanaka S., Tsuda M., Endo S., Kato H., Sonobe H., Minami A., Hiraga H., Nishihara H., Sawa H., Nagashima K., Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 3843 3848 (Pubitemid 32249859)
117. Barco R., Hunt L. B., Frump A. L., Garcia C. B., Benesh A., Caldwell R. L., Eid J. E., The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway Molecular Biology of the Cell 2007 18 10 4003 4012 (Pubitemid 47519491)
118. Dobashi Y., Suzuki S., Sato E., Hamada Y., Yanagawa T., Ooi A., EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors Modern Pathology 2009 22 10 1328 1340
119. Friedrichs N., Trautmann M., Endl E., Sievers E., Kindler D., Wurst P., Czerwitzki J., Steiner S., Renner M., Penzel R., Koch A., Larsson O., Tanaka S., Kawai A., Schirmacher P., Mechtersheimer G., Wardelmann E., Buettner R., Hartmann W., Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma International Journal of Cancer 2011 129 7 1564 1575
120. Palman C., Bowen-Pope D. F., Brooks J. J., Platelet-derived growth factor receptor ( -subunit) immunoreactivity in soft tissue tumors Laboratory Investigation 1992 66 1 108 115
121. Heinrich M. C., Griffith D. J., Druker B. J., Wait C. L., Ott K. A., Zigler A. J., Inhibition of c-kit receptor tyrosine kinase activity by STI 571 a selective tyrosine kinase inhibitor Blood 2000 96 3 925 932 (Pubitemid 30618049)
122. Barbashina V., Benevenia J., Aviv H., Tsai J., Patterson F., Aisner S., Cohen S., Fernandes H., Skurnick J., Hameed M., Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases Journal of Cancer Research and Clinical Oncology 2002 128 11 610 616 (Pubitemid 35435558)
123. Demetri G. D., Von Mehren M., Blanke C. D., Van Den Abbeele A. D., Eisenberg B., Roberts P. J., Heinrich M. C., Tuveson D. A., Singer S., Janicek M., Fletcher J. A., Silverman S. G., Silberman S. L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druker B. J., Corless C., Fletcher C. D. M., Joensuu H., Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors New England Journal of Medicine 2002 347 7 472 480 (Pubitemid 34879334)
124. Tamborini E., Bonadiman L., Greco A., Gronchi A., Riva C., Bertulli R., Casali P. G., Pierotti M. A., Pilotti S., Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor Tyrosine Kinase Receptors in Synovial Sarcoma Clinical Cancer Research 2004 10 3 938 943 (Pubitemid 38198893)
125. Verweij J., Casali P. G., Zalcberg J., LeCesne A., Reichardt P., Blay J. Y., Issels R., Van Oosterom A., Hogendoorn P. C. W., Van Glabbeke M., Bertulli R., Judson I., Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial The Lancet 2004 364 9440 1127 1134 (Pubitemid 39296599)
126. Thomas D. G., Giordano T. J., Sanders D., Biermann S., Sondak V. K., Trent J. C., Yu D., Pollock R. E., Baker L., Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/ neu in synovial sarcoma Cancer 2005 103 4 830 838 (Pubitemid 40216413)
127. Lpez-Guerrero J. A., Navarro S., Noguera R., Carda C., Farinas S. C., Pellin A., Llombart-Bosch A., Mutational analysis of the c-KIT and PDGFR in a series of molecularly well-characterized synovial sarcomas Diagnostic Molecular Pathology 2005 14 3 134 139 (Pubitemid 41391794)
128. Krskov L., Kalinov M., Bzov H., Mrhalov M., Sumerauer D., Kodet R., Molecular and immunohistochemical analyses of BCL2, KI-67, andcyclin D1 expression in synovial sarcoma Cancer Genetics and Cytogenetics 2009 193 1 1 8
129. Rikhof B., de Jong S., Suurmeijer A. J. H., Meijer C., Van Der Graaf W. T. A., The insulin-like growth factor system and sarcomas Journal of Pathology 2009 217 4 469 482
130. Erkizan H. V., Kong Y., Merchant M., Schlottmann S., Barber-Rotenberg J. S., Yuan L., Abaan O. D., Chou T. H., Dakshanamurthy S., Brown M. L., Ren A., Toretsky J. A., A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma Nature Medicine 2009 15 7 750 756
131. Raaphorst F. M., Deregulated expression of polycomb-group oncogenes in human malignant lymphomas and epithelial tumors Human Molecular Genetics 2005 14 1 R93 R100
132. Takihara Y., Role of Polycomb-group genes in sustaining activities of normal and malignant stem cells International Journal of Hematology 2008 87 1 25 34
133. Dimri M., Bommi P. V., Sahasrabuddhe A. A., Khandekar J. D., Dimri G. P., Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells Carcinogenesis 2010 31 3 489 495
134. Kemp C. D., Rao M., Xi S., Inchauste S., Mani H., Fetsch P., Filie A., Zhang M., Hong J. A., Walker R. L., Zhu Y. J., Ripley R. T., Mathur A., Liu F., Yang M., Meltzer P. A., Marquez V. E., de Rienzo A., Bueno R., Schrump D. S., Polycomb repressor complex-2 is a novel target for mesothelioma therapy Clinical Cancer Research 2012 18 1 77 90
135. Ray-Coquard I., Le Cesne A., Whelan J. S., Schoffski P., Bui B. N., Verweij J., Marreaud S., Van Glabbeke M., Hogendoorn P., Blay J. Y., A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens Oncologist 2008 13 4 467 473 (Pubitemid 351679928)
136. Chugh R., Wathen J. K., Maki R. G., Benjamin R. S., Patel S. R., Myers P. A., Priebat D. A., Reinke D. K., Thomas D. G., Keohan M. L., Samuels B. L., Baker L. H., Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model Journal of Clinical Oncology 2009 27 19 3148 3153
137. Grossman S. R., Perez M., Kung A. L., Joseph M., Mansur C., Xiao Z. X., Kumar S., Howley P. M., Livingston D. M., p300/MDM2 complexes participate in MDM2-mediated p53 degradation Molecular Cell 1998 2 4 405 415 (Pubitemid 128381293)
138. Silverman E. S., Du J., Williams A. J., Wadgaonkar R., Drazen J. M., Collins T., cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1) Biochemical Journal 1998 336 1 183 189 (Pubitemid 28532575)
139. Hoffmeister A., Ropolo A., Vasseur S., Mallo G. V., Bodeker H., Ritz-Laser B., Dressler G. R., Vaccaro M. I., Dagorn J. C., Moreno S., Iovanna J. L., The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter Journal of Biological Chemistry 2002 277 25 22314 22319 (Pubitemid 34967198)
140. Ratineau C., Petry M. W., Mutoh H., Leiter A. B., Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD Journal of Biological Chemistry 2002 277 11 8847 8853 (Pubitemid 34952952)
141. Yu J., de Belle I., Liang H., Adamson E. D., Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses Molecular Cell 2004 15 1 83 94 (Pubitemid 38850221)
142. Minsky N., Oren M., The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression Molecular Cell 2004 16 4 631 639 (Pubitemid 39531885)
143. Lo H. W., Hsu S. C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J. Y., Hung M. C., Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway Cancer Cell 2005 7 6 575 589 (Pubitemid 40799250)
144. Hall M., Bates S., Peters G., Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins Oncogene 1995 11 8 1581 1588
145. Sawaya B. E., Khalilit K., Mercer W. E., Denisova L., Amini S., Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription Journal of Biological Chemistry 1998 273 32 20052 20057 (Pubitemid 28377557)
146. Ohlsson C., Kley N., Werner H., Leroith D., p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1 Endocrinology 1998 139 3 1101 1107 (Pubitemid 28510128)
147. Zhang X., Liu Y., Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1 American Journal of PhysiologyRenal Physiology 2003 284 6 F1216 F1225
148. Bond G. L., Hu W., Bond E. E., Robins H., Lutzker S. G., Arva N. C., Bargonetti J., Bartel F., Taubert H., Wuerl P., Onel K., Yip L., Hwang S. J., Strong L. C., Lozano G., Levine A. J., A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 2004 119 5 591 602 (Pubitemid 39535748)
149. Clair S. S., Giono L., Varmeh-Ziaie S., Resnick-Silverman L., Liu W. J., Padi A., Dastidar J., DaCosta A., Mattia M., Manfredi J. J., DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter Molecular Cell 2004 16 5 725 736 (Pubitemid 39586531)
150. Sengupta S., Shimamoto A., Koshiji M., Pedeux R., Rusin M., Spillare E. A., Shen J. C., Huang L. E., Lindor N. M., Furuichi Y., Harris C. C., Tumor suppressor p53 represses transcription of RECQ4 helicase Oncogene 2005 24 10 1738 1748 (Pubitemid 40461130)
151. Ravasi T., Suzuki H., Cannistraci C. V., Katayama S., Bajic V. B., Tan K., Akalin A., Schmeier S., Kanamori-Katayama M., Bertin N., Carninci P., Daub C. O., Forrest A. R. R., Gough J., Grimmond S., Han J. H., Hashimoto T., Hide W., Hofmann O., Kawaji H., Kubosaki A., Lassmann T., van Nimwegen E., Ogawa C., Teasdale R. D., Tegnér J., Lenhard B., Teichmann S. A., Arakawa T., Ninomiya N., Murakami K., Tagami M., Fukuda S., Imamura K., Kai C., Ishihara R., Kitazume Y., Kawai J., Hume D. A., Ideker T., Hayashizaki Y., An atlas of combinatorial transcriptional regulation in mouse and man Cell 2010 140 5 744 752
152. de Bruijn D. R. H., van Dijk A. H. A., Willemse M. P., van Kessel A. G., The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4 Oncogene 2008 27 5 653 662 (Pubitemid 351158898)
153. Rual J. F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G. F., Gibbons F. D., Dreze M., Ayivi-Guedehoussou N., Klitgord N., Simon C., Boxem M., Milstein S., Rosenberg J., Goldberg D. S., Zhang L. V., Wong S. L., Franklin G., Li S., Albala J. S., Lim J., Fraughton C., Llamosas E., Cevik S., Bex C., Lamesch P., Sikorski R. S., Vandenhaute J., Zoghbi H. Y., Smolyar A., Bosak S., Sequerra R., Doucette-Stamm L., Cusick M. E., Hill D. E., Roth F. P., Vidal M., Towards a proteome-scale map of the human protein-protein interaction network Nature 2005 437 7062 1173 1178 (Pubitemid 41509356)